CDX2 and in situ carcinoma: In our present case, confirming its tumor suppressor role, CDX2 exhibited strong and diffuse expression in IM, dysplasia, carcinoma in situ, and well-differentiated invasive carcinoma, while displaying focal and weak expression in poorly differentiated areas of signet ring cells.